• Aaronson, D.S.,Horvath, C.M., 2002. A road map for those who don't know JAK-STAT. Science, 296, 1653-1655.

  • Andrejeva, J., Poole, E., Young, D.F., Goodbourn, S.,Randall, R.E., 2002. The p127 subunit (DDB1) of the UV-DNA damage repair binding protein is essential for the targeted degradation of STAT1 by the V protein of the paramyxovirus simian virus 5. J Virol, 76, 11379-11386.

  • Begitt, A., Droescher, M., Meyer, T., Schmid, C.D., Baker, M., Antunes, F., Knobeloch, K.P., Owen, M.R., Naumann, R., Decker, T.,Vinkemeier, U., 2014. STAT1-cooperative DNA binding distinguishes type 1 from type 2 interferon signaling. Nat Immunol, 15, 168-176.

  • Belsham, G.J., 2005. Translation and replication of FMDV RNA. Curr Top Microbiol Immunol, 288, 43-70.

  • Birtley, J.R., Knox, S.R., Jaulent, A.M., Brick, P., Leatherbarrow, R.J.,Curry, S., 2005. Crystal structure of foot-and-mouth disease virus 3C protease. New insights into catalytic mechanism and cleavage specificity. J Biol Chem, 280, 11520-11527.

  • Darnell, J.E., Jr., Kerr, I.M.,Stark, G.R., 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science, 264, 1415-1421.

  • De Los Santos, T., De Avila Botton, S., Weiblen, R.,Grubman, M.J., 2006. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J Virol, 80, 1906-1914.

  • De Los Santos, T., Diaz-San Segundo, F.,Grubman, M.J., 2007. Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J Virol, 81, 12803-12815.

  • Devaux, P., Von Messling, V., Songsungthong, W., Springfeld, C.,Cattaneo, R., 2007. Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation. Virology, 360, 72-83.

  • Didcock, L., Young, D.F., Goodbourn, S.,Randall, R.E., 1999. The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J Virol, 73, 9928-9933.

  • Du, Y., Bi, J., Liu, J., Liu, X., Wu, X., Jiang, P., Yoo, D., Zhang, Y., Wu, J., Wan, R., Zhao, X., Guo, L., Sun, W., Cong, X., Chen, L.,Wang, J., 2014. 3Cpro of foot-and-mouth disease virus antagonizes the interferon signaling pathway by blocking STAT1/STAT2 nuclear translocation. J Virol, 88, 4908-4920.

  • Dunn, G.P., Ikeda, H., Bruce, A.T., Koebel, C., Uppaluri, R., Bui, J., Chan, R., Diamond, M., White, J.M., Sheehan, K.C.,Schreiber, R.D., 2005. Interferon-gamma and cancer immunoediting. Immunol Res, 32, 231-245.

  • Dunn, G.P., Koebel, C.M.,Schreiber, R.D., 2006. Interferons, immunity and cancer immunoediting. Nat Rev Immunol, 6, 836-848.

  • Fros, J.J., Liu, W.J., Prow, N.A., Geertsema, C., Ligtenberg, M., Vanlandingham, D.L., Schnettler, E., Vlak, J.M., Suhrbier, A., Khromykh, A.A.,Pijlman, G.P., 2010. Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling. J Virol, 84, 10877-10887.

  • Grubman, M.J., 1980. The 5' end of foot-and-mouth disease virion RNA contains a protein covalently linked to the nucleotide pUp. Arch Virol, 63, 311-315.

  • Grubman, M.J.,Baxt, B., 2004. Foot-and-mouth disease. Clin Microbiol Rev, 17, 465-493.

  • Grubman, M.J., Zellner, M., Bablanian, G., Mason, P.W.,Piccone, M.E., 1995. Identification of the active-site residues of the 3C proteinase of foot-and-mouth disease virus. Virology, 213, 581-589.

  • Hu, Y., Cong, X., Chen, L., Qi, J., Wu, X., Zhou, M., Yoo, D., Li, F., Sun, W., Wu, J., Zhao, X., Chen, Z., Yu, J., Du, Y.,Wang, J., 2016. Synergy of TLR3 and 7 ligands significantly enhances function of DCs to present inactivated PRRSV antigen through TRIF/MyD88-NF-κB signaling pathway. Sci Rep, 6, 23977.

  • Ikeda, H., Old, L.J.,Schreiber, R.D., 2002. The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev, 13, 95-109.

  • Jamal, S.M.,Belsham, G.J., 2018. Molecular epidemiology, evolution and phylogeny of foot-and-mouth disease virus. Infect Genet Evol, 59, 84-98.

  • Kotenko, S.V., 2011. IFN-lambdas. Curr Opin Immunol, 23, 583-590.

  • Kubota, T., Yokosawa, N., Yokota, S., Fujii, N., Tashiro, M.,Kato, A., 2005. Mumps virus V protein antagonizes interferon without the complete degradation of STAT1. J Virol, 79, 4451-4459.

  • Kulkarni, A., Ganesan, P.,O'donnell, L.A., 2016. Interferon Gamma:Influence on Neural Stem Cell Function in Neurodegenerative and Neuroinflammatory Disease. Clin Med Insights Pathol, 9, 9-19.

  • Lang, C., Hildebrandt, A., Brand, F., Opitz, L., Dihazi, H.,Luder, C.G., 2012. Impaired chromatin remodelling at STAT1-regulated promoters leads to global unresponsiveness of Toxoplasma gondii-infected macrophages to IFN-gamma. PLoS Pathog, 8, e1002483.

  • Lasfar, A., Cook, J.R., Cohen Solal, K.A., Reuhl, K., Kotenko, S.V., Langer, J.A.,Laskin, D.L., 2014. Critical role of the endogenous interferon ligand-receptors in type I and type II interferons response. Immunology, 142, 442-452.

  • Li, D., Wei, J., Yang, F., Liu, H.N., Zhu, Z.X., Cao, W.J., Li, S., Liu, X.T., Zheng, H.X.,Shu, H.B., 2016. Foot-and-mouth disease virus structural protein VP3 degrades Janus kinase 1 to inhibit IFN-γ signal transduction pathways. Cell Cycle, 15, 850-860.

  • Mcbride, K.M., Banninger, G., Mcdonald, C.,Reich, N.C., 2002. Regulated nuclear import of the STAT1 transcription factor by direct binding of importin-alpha. Embo j, 21, 1754-1763.

  • Miller, D.M., Rahill, B.M., Boss, J.M., Lairmore, M.D., Durbin, J.E., Waldman, J.W.,Sedmak, D.D., 1998. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med, 187, 675-683.

  • Montgomery, S.A.,Johnston, R.E., 2007. Nuclear import and export of Venezuelan equine encephalitis virus nonstructural protein 2. J Virol, 81, 10268-10279.

  • Mori, M., Yoneyama, M., Ito, T., Takahashi, K., Inagaki, F.,Fujita, T., 2004. Identification of Ser-386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation. J Biol Chem, 279, 9698-9702.

  • O'donnell, L.A., Conway, S., Rose, R.W., Nicolas, E., Slifker, M., Balachandran, S.,Rall, G.F., 2012. STAT1-independent control of a neurotropic measles virus challenge in primary neurons and infected mice. J Immunol, 188, 1915-1923.

  • Palosaari, H., Parisien, J.P., Rodriguez, J.J., Ulane, C.M.,Horvath, C.M., 2003. STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J Virol, 77, 7635-7644.

  • Pizzi, M., 1950. Sampling variation of the fifty percent end-point, determined by the Reed-Muench (Behrens) method. Hum Biol, 22, 151-190.

  • Platanias, L.C., 2005. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol, 5, 375-386.

  • Randall, R.E.,Goodbourn, S., 2008. Interferons and viruses:an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol, 89, 1-47.

  • Reid, S.P., Leung, L.W., Hartman, A.L., Martinez, O., Shaw, M.L., Carbonnelle, C., Volchkov, V.E., Nichol, S.T.,Basler, C.F., 2006. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J Virol, 80, 5156-5167.

  • Robertson, B.H., Grubman, M.J., Weddell, G.N., Moore, D.M., Welsh, J.D., Fischer, T., Dowbenko, D.J., Yansura, D.G., Small, B.,Kleid, D.G., 1985. Nucleotide and amino acid sequence coding for polypeptides of foot-and-mouth disease virus type A12. J Virol, 54, 651-660.

  • Rodriguez, J.J., Parisien, J.P.,Horvath, C.M., 2002. Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J Virol, 76, 11476-11483.

  • Rodriguez, J.J., Wang, L.F.,Horvath, C.M., 2003. Hendra virus V protein inhibits interferon signaling by preventing STAT1 and STAT2 nuclear accumulation. J Virol, 77, 11842-11845.

  • Schoenborn, J.R.,Wilson, C.B., 2007. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol, 96, 41-101.

  • Shuai, K.,Liu, B., 2003. Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol, 3, 900-911.

  • Simmons, J.D., White, L.J., Morrison, T.E., Montgomery, S.A., Whitmore, A.C., Johnston, R.E.,Heise, M.T., 2009. Venezuelan equine encephalitis virus disrupts STAT1 signaling by distinct mechanisms independent of host shutoff. J Virol, 83, 10571-10581.

  • Stenfeldt, C., Diaz-San Segundo, F., De Los Santos, T., Rodriguez, L.L.,Arzt, J., 2016. The Pathogenesis of Foot-and-Mouth Disease in Pigs. Front Vet Sci, 3, 41.

  • Vidy, A., El Bougrini, J., Chelbi-Alix, M.K.,Blondel, D., 2007. The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1. J Virol, 81, 4255-4263.

  • Wang, C., Feng, H., Zhang, X., Li, K., Yang, F., Cao, W., Liu, H., Gao, L., Xue, Z., Liu, X., Zhu, Z.,Zheng, H., 2021. Porcine Picornavirus 3C Protease Degrades PRDX6 to Impair PRDX6-mediated Antiviral Function. Virol Sin, 36, 948-957.

  • Wang, D., Fang, L., Li, K., Zhong, H., Fan, J., Ouyang, C., Zhang, H., Duan, E., Luo, R., Zhang, Z., Liu, X., Chen, H.,Xiao, S., 2012. Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling. J Virol, 86, 9311-9322.

  • Wang, D., Fang, L., Luo, R., Ye, R., Fang, Y., Xie, L., Chen, H.,Xiao, S., 2010. Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced type I interferon transcription by decreasing interferon regulatory factor 3/7 in protein levels. Biochemical and Biophysical Research Communications, 399, 72-78.

  • Wu, X., Qi, J., Cong, X., Chen, L., Hu, Y., Yoo, D., Wang, G., Tian, F., Li, F., Sun, W., Chen, Z., Guo, L., Wu, J., Li, J., Wang, J., Zhao, X.,Du, Y., 2018. Establishment and Characterization of a High and Stable Porcine CD163-Expressing MARC-145 Cell Line. BioMed Research International, 2018, 1-9.

  • Yokosawa, N., Kubota, T.,Fujii, N., 1998. Poor induction of interferon-induced 2',5'-oligoadenylate synthetase (2-5 AS) in cells persistently infected with mumps virus is caused by decrease of STAT-1 alpha. Arch Virol, 143, 1985-1992.

  • Young, D.F., Didcock, L., Goodbourn, S.,Randall, R.E., 2000. Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology, 269, 383-390.